Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Receivables - Other (2016 - 2025)

Elevance Health (ELV) has disclosed Receivables - Other for 17 consecutive years, with $6.3 billion as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 4.84% to $6.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 billion through Dec 2025, up 4.84% year-over-year, with the annual reading at $6.3 billion for FY2025, 4.84% up from the prior year.
  • Receivables - Other for Q4 2025 was $6.3 billion at Elevance Health, down from $7.7 billion in the prior quarter.
  • The five-year high for Receivables - Other was $7.7 billion in Q3 2025, with the low at $1.5 billion in Q4 2021.
  • Average Receivables - Other over 5 years is $4.9 billion, with a median of $5.2 billion recorded in 2023.
  • The sharpest move saw Receivables - Other plummeted 47.0% in 2021, then surged 186.53% in 2022.
  • Over 5 years, Receivables - Other stood at $1.5 billion in 2021, then soared by 186.53% to $4.3 billion in 2022, then grew by 25.76% to $5.4 billion in 2023, then increased by 11.3% to $6.0 billion in 2024, then increased by 4.84% to $6.3 billion in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $6.3 billion, $7.7 billion, and $7.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.